Research Tracker›Biomarker Atlas›Gulf War Illness›PON1 Q192R polymorphism

PON1 Q192R polymorphism in Gulf War Illness

In Gulf War Illness (GWI, Gulf War Syndrome), the direction of change for PON1 Q192R polymorphism, also described as Genetic exposure susceptibility, is inconsistent across studies that used Genotype-stratified as the reference group. The cited literature links this alteration to pesticide exposure response. The evidence summarised here comes from Gean et al. 2021 and reflects averages across cohorts rather than any single patient's result.

↕ InconsistentExposure

Summary

Direction in Gulf War Illness↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryExposure
Also described asGenetic exposure susceptibility
Compared againstGenotype-stratified
Associated symptomsPesticide exposure response
Test typeBlood test (serum / plasma / whole blood)
SourceGean et al. 2021 — doi:10.1016/j.lfs.2021.119456
Condition atlasGulf War Illness Biomarker Atlas

Related Exposure markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is PON1 Q192R polymorphism high or low in Gulf War Illness?

Mixed. Some studies report higher and others lower PON1 Q192R polymorphism in Gulf War Illness compared with Genotype-stratified, so no single direction is established. Source: Gean et al. 2021.

What symptoms is PON1 Q192R polymorphism associated with in Gulf War Illness?

The cited literature associates this marker with Pesticide exposure response. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures PON1 Q192R polymorphism?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal PON1 Q192R polymorphism result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. PON1 Q192R polymorphism findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). PON1 Q192R polymorphism in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/pon1-q192r-polymorphism.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.